ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Grants Awarded To Develop Special Populations Networks. AACR Honors Feinstein, Khayat.

April 14, 2000

Turmoil in Texas: Texas Agency Funded $11 Million Grant Without Peer Review; Official Resigns

November 30, 2012

Adding Aresenic To Therapy Improves APL Survival

July 27, 2007

In Brief: Nearly One-Third Of Cancer Radiotherapy Facilities Use Outdated Methods – Clark

August 9, 1974

Duke Deans Acknowledge Withholding Key Document From Outside Reviewers

January 14, 2011

Emphasis On Early Disease In Clinical Trials, Early Lung Cancer Detection Seen As “Landmark”

September 19, 1975